MANILA, Philippines — Amid rumors of government destabilization, President Ferdinand Marcos Jr. on Wednesday, December 3, announced an increase in the base pay of military and uniformed personnel (MUP ...

If you are wondering whether Exponent is a bargain or a trap at today’s price, you are not alone. This breakdown is designed to help you see what the market might be missing. The stock has slipped 1.6 ...

SALT LAKE CITY - Recursion (NASDAQ:RXRX) will present new clinical data from its ongoing TUPELO Phase 1b/2 trial of REC-4881 in Familial Adenomatous Polyposis (FAP) during a company webinar scheduled ...

Exponent plans to open over 15 exclusive touch points across Bengaluru by the end of FY26. Exponent Energy, a Bengaluru-based energy-tech company, has entered the three-wheeler EV retail segment with ...

The United States is trying to reclaim Bagram Air Base in Afghanistan "back" from the Taliban, President Donald Trump said on Thursday. Trump made the surprise announcement about the base during a ...

Washington — President Trump said Friday he is canceling all orders signed by former President Joe Biden using an autopen, a mechanical device that reproduces signatures. "Any document signed" by ...

If you're looking for web links only in Google Search results, create a custom search shortcut for your browser. Peter is a writer and editor for the CNET How-To team. He has been covering technology, ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...